About Purgo Biologics

About Purgo Biologics

Founded in 1999, Purgo Biologics strives to become one of the leading global companies in oral health care with its focus on safe biomaterials for soft tissue and bone regeneration. 

Based on the specialized experiences accumulated by our outstanding research personnel, Purgo Research and Development Center based in Seoul is thriving to become the best in the world, specifically in the expertise of oral biomaterials for soft tissue and bone regeneration.

All members of Research and Development Center are pursuing optimized technical developments with various clinical studies, cooperative research with the governments, clinicians, and educational institutions.

Surface Energy

Harmonized Porosity

Hydrophilicity

Purity

Our Vision

Purgo focuses on Bone & Membrane Only

Our Vision

Purgo focuses on Bone & Membrane Only

Our Mission & Innovation Strategy

Purgo Biologics has endeavored to contribute from the development of global dental treatment and clinical science to the improvement of human oral health by continuously supplying products through scientific and structured processes over the past 20 years to clinical professionals around the world.

Stepping into dentistry since 1999, we devoted ourselves to providing regenerative and bio-compatible products. We have continued research collaboration for more than 10 years with experts in various clinical fields and numerous dental clinicians around the world. Our deep analysis directed us to biomimetic as the most effective and safe regeneration solution for the different types of tissues. Since then, we continued to focus another 10 years, specifically on the regeneration of alveolar bone and regeneration of soft tissues, enabling us to supply a broader product profile to clinicians around the world.

The company Milestones

Foundation

1999 - Established Purgo Biologics

2000 - Concluded Domestic supply contract with ACE Surgical Supply (USA)

2001 - Concluded domestic supply contract with Hartzell and Son (USA)

2002 - Signed a distributor contract with Rocky Mountain Tissue Bank (USA)

2003 - Signed an exclusive distributor contract in Asia of Biomatlante (France), Released sales of Happylon®

2005 - Established Purgo Tissue Bank, Released domestic sales of suture of Shirakawa (Japan)

Bone & Membrane Specialization

2010 - Established Purgo R&D Center (Pangyo)

2011 - Obtained Certificate of Manufacturer of Medical Devices from Korean MFDS

2012 - Received Certificate of Registration of Quality Management System ISO 13485:2016                        - Obtained CE certificate of OpenTex, Obtained KGMP (Korea Good Manufacturing Practice) Korean MFDS certificate  

2013 - THE Graft was approved as a manufacturer item by Korean MFDS, Obtained TFDA (Taiwan) certificate of OpenTex, Obtained CMDCAS certificate of OpenTex,

Concluded domestic supply contract of resorbable collagen membrane, Authorized as a venture company

Global Growth

2014 - Biotex was approved as a manufacturer item by the Korean MFDA

2015 - OpenTex-TR was approved as a manufactured item by Korean MFDA;  Obtained TFDA (Taiwan) & CE certificate of THE Graft, Concluded global sales contract of THE Graft in 18 EU countries

2016 - The factory and laboratory were relocated to cover global supply, A randomized clinical trial lecture of THE Graft was published in SCI journal        

2017 - Obtained CE certificate of THE Graft, OpenTex, OpenTex-TR, BioTex,  Obtained Health Canada certificate of THE Graft, OpenTex, OprenTex-TR, BioTex,

Obtained Roszdravnadzor (Russia) certificate of THE Graft, OpenTex, OprenTex-TR, BioTex, Concluded supply contract in Portugal, Spain & Canada, Selected as a specialist company in human resource development       

Together to the next level!

2018 - Obtained MDSAP certificate (ISO 13485:2016)      Obtained FDA, CDSCO certificate of THE Graft,              Obtained ANVISA (Brazil) certificate of Biotex,              Selected as Frontier Export Company                                       

2019 - Obtained certificate of THE Graft in Ukraine,           Obtained FDA (USA) certificate of Biotex,                Obtained NMPA (CFDA) certificate of THE Graft 

2020 - Built up the "Strategic Cooperative Partnership" with CareCapital

2021 - Purgo HQ moved to Pangyo Technovalley, 

Purgo Europe Branch opening as Europe Importer

The company Milestones

Foundation

1999 - Established Purgo Biologics

2000 - Concluded Domestic supply contract with ACE Surgical Supply (USA)

2001 - Concluded domestic supply contract with Hartzell and Son (USA)

2002 - Signed a distributor contract with Rocky Mountain Tissue Bank (USA)

2003 - Signed an exclusive distributor contract in Asia of Biomatlante (France), Released sales of Happylon®

2005 - Established Purgo Tissue Bank, Released domestic sales of suture of Shirakawa (Japan)

Bone & Membrane Specialization

2010 - Established Purgo R&D Center (Pangyo)

2011 - Obtained Certificate of Manufacturer of Medical Devices from Korean MFDS

2012 - Received Certificate of Registration of Quality Management System ISO 13485:2016, Obtained CE certificate of OpenTex, Obtained KGMP (Korea Good Manufacturing Practice) Korean MFDS certificate  

2013 - THE Graft was approved as a manufacturer item by Korean MFDS, Obtained TFDA (Taiwan) certificate of OpenTex, Obtained CMDCAS certificate of OpenTex,

Concluded domestic supply contract of resorbable collagen membrane, Authorized as a venture company

Global Growth

2014 - Biotex was approved as a manufacturer item by the Korean MFDA

2015 - OpenTex-TR was approved as a manufactured item by Korean MFDA;  Obtained TFDA (Taiwan) & CE certificate of THE Graft, Concluded global sales contract of THE Graft in 18 EU countries

2016 - The factory and laboratory were relocated to cover global supply, A randomized clinical trial lecture of THE Graft was published in SCI journal        

2017 - Obtained CE certificate of THE Graft, OpenTex, OpenTex-TR, BioTex,  Obtained Health Canada certificate of THE Graft, OpenTex, OprenTex-TR, BioTex,

Obtained Roszdravnadzor (Russia) certificate of THE Graft, OpenTex, OprenTex-TR, BioTex, Concluded supply contract in Portugal, Spain & Canada, Selected as a specialist company in human resource development       

Together to the next level!

2018 - Obtained MDSAP certificate (ISO 13485:2016),  Obtained FDA, CDSCO certificate of THE Graft, Obtained ANVISA (Brazil) certificate of Biotex, Selected as Frontier Export Company                                       

2019 - Obtained certificate of THE Graft in Ukraine, Obtained FDA (USA) certificate of Biotex, Obtained NMPA (CFDA) certificate of THE Graft 

2020 - Built up the "Strategic Cooperative Partnership" with CareCapital

2021 - Purgo HQ moved to Pangyo Technovalley, 

Purgo Europe Branch opening as Europe Importer

Quality Management

Regulatory

KTR-ABBA-7058 (GMP)
Manage all the processes with a quality system designed to manufacture safe and effective products.
Control and assess quality with the latest analytical instrument.

QA/QC

EN ISO 13485:2016 (NSAI)
Establish a quality management system following quality control standards.
Manage relevant documents based on international standards.
Assess the quality of products by performing tests and analysis.
Updates and internal audits are regularly performed for preventative measures.
Assess the conformity of quality management with KGMP, ISO, MDSAP.

Global Standards

DMSAP ISO13485:2016 (NSAI)
Comply with the laws and regulations of countries.
Continuously improve quality and innovate.
Contribute to growth by continuously delivering customer satisfaction.

Our CI

STOP

The first story captures the research and development Purgo has learned and is based on clinical observation over the past 20 years. We started to realize that human beings as subjects reproducing the wonders in nature are in harmony with grand nature.

Observing the laws of nature, we have tried to reflect the learnings and knowledge we have gained in our products. Acquiring the common belief of designing safe and nature-friendly products, in harmony and in resemblance to the natural cycles, our products present the nature itself with designing safe.

Play Video
Play Video

FORGET

We captured the insights gained from observing numerous dental regenerative trials in the second story. That was to show the importance of using appropriate regenerative materials, that to obtain a satisfactory clinical result, product quality shares the equivalent level of importance to the procedure type and quality to achieve excellent results.

What is conveyed in this story is the desire we hold as a company solely aiming for a better future for clinicians, a nature-friendly product suitable for the clinical environment. We continuously developed and invested in producing user-friendly medical devices that clinicians can use with confidence and comfort.

Play Video

BYE

The last story expresses the importance of ‘convenience’ as one of the critical factors of efficiency which determines successful clinical results. To obtain such results, the operator’s proficiency in clinical procedures, through product material knowledge, and the ability to choose the right solution to fit circumstances should be accompanied by various tools and materials that add convenience.

In our stories we tried to demonstrate the support which has been provided to our clients, and the services available that enable successful clinical outcomes. To provide our clients with products that promise satisfactory results and more product portfolio that equips clinicians for convenient choice with broader options, we have been focusing comprehensively on manufacturing and supplying our products with our own reliable and trustful technology.

Play Video

Get in Touch

Manufacturer Purgo Biologics Inc.

812, 27, Dunchon-daero 457beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13219, Korea
Tel.: +82 70 75 49 29 72
overseas@purgobiologics.com

EU Importer Purgo Biologics Europe SAS

1 Square Félix Bloch, Pôle Activ Océan 85300 Challans France Tel: +33 (0)2 28 10 61 02
europe@purgobiologics.com

EU Importer Purgo Biologics Europe SAS

1 Square Félix Bloch,
Pôle Activ Océan 85300 Challans France
Tel: +33 (0)2 28 10 61 02
europe@purgobiologics.com


ATTENTION

This area is reserved exclusively for medical professionals.
I hereby confirm that I am a medical professional -

I'm a Medical Professional

If you are a patient,

I'm a Patient